As Cerner (CERN) Stock Rose, Creative Planning Trimmed Stake by $461,642; Teva Pharmaceutical Industries LTD (TEVA) Shareholder Shelter Mutual Insurance Co Has Upped Position

December 23, 2017 - By Maria Brooks

Shelter Mutual Insurance Co increased its stake in Teva Pharmaceutical Industries Ltd (TEVA) by 910% based on its latest 2017Q3 regulatory filing with the SEC. Shelter Mutual Insurance Co bought 36,400 shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 40,400 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $711,000, up from 4,000 at the end of the previous reported quarter. Shelter Mutual Insurance Co who had been investing in Teva Pharmaceutical Industries Ltd for a number of months, seems to be bullish on the $19.05 billion market cap company. The stock increased 1.35% or $0.25 during the last trading session, reaching $18.75. About 16.12 million shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since December 23, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Creative Planning decreased its stake in Cerner Corp (CERN) by 1.85% based on its latest 2017Q3 regulatory filing with the SEC. Creative Planning sold 6,502 shares as the company’s stock rose 14.16% with the market. The institutional investor held 344,469 shares of the edp services company at the end of 2017Q3, valued at $24.57 million, down from 350,971 at the end of the previous reported quarter. Creative Planning who had been investing in Cerner Corp for a number of months, seems to be less bullish one the $22.40 billion market cap company. The stock decreased 0.75% or $0.51 during the last trading session, reaching $67.38. About 2.51 million shares traded or 16.44% up from the average. Cerner Corporation (NASDAQ:CERN) has risen 19.54% since December 23, 2016 and is uptrending. It has outperformed by 2.84% the S&P500.

Shelter Mutual Insurance Co, which manages about $320.56M US Long portfolio, decreased its stake in Abbott Labs (NYSE:ABT) by 8,800 shares to 93,300 shares, valued at $4.98 million in 2017Q3, according to the filing. It also reduced its holding in Visa Inc/A (NYSE:V) by 14,500 shares in the quarter, leaving it with 154,840 shares, and cut its stake in Lowe’s Corp (NYSE:LOW).

Among 33 analysts covering Teva Pharma (NYSE:TEVA), 8 have Buy rating, 5 Sell and 20 Hold. Therefore 24% are positive. Teva Pharma had 122 analyst reports since July 21, 2015 according to SRatingsIntel. Argus Research maintained it with “Buy” rating and $82 target in Tuesday, July 28 report. Morgan Stanley maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Thursday, October 5. Morgan Stanley has “Underweight” rating and $15 target. The rating was maintained by Mizuho on Wednesday, November 16 with “Neutral”. The firm has “Underperform” rating by RBC Capital Markets given on Friday, November 3. The rating was maintained by Piper Jaffray on Friday, July 14 with “Hold”. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Buy” rating by Mizuho on Tuesday, May 10. Bank of America upgraded the shares of TEVA in report on Tuesday, January 31 to “Buy” rating. Cowen & Co maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Wednesday, April 5 with “Outperform” rating. The firm has “Hold” rating given on Wednesday, August 2 by Mizuho. BTIG Research upgraded Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Monday, September 11 to “Buy” rating.

Since August 11, 2017, it had 0 insider purchases, and 6 sales for $28.54 million activity. BURKE ZANE M also sold $6.34 million worth of Cerner Corporation (NASDAQ:CERN) on Friday, September 1. ILLIG CLIFFORD W sold $7.33M worth of stock. 4,000 shares were sold by Battaglioli Michael R., worth $279,560. Another trade for 60,000 shares valued at $4.08 million was made by SIMS RANDY D on Friday, September 1.

Analysts await Cerner Corporation (NASDAQ:CERN) to report earnings on February, 8. They expect $0.58 earnings per share, up 1.75% or $0.01 from last year’s $0.57 per share. CERN’s profit will be $192.80 million for 29.04 P/E if the $0.58 EPS becomes a reality. After $0.57 actual earnings per share reported by Cerner Corporation for the previous quarter, Wall Street now forecasts 1.75% EPS growth.

Investors sentiment increased to 0.98 in 2017 Q3. Its up 0.11, from 0.87 in 2017Q2. It is positive, as 44 investors sold CERN shares while 209 reduced holdings. 59 funds opened positions while 190 raised stakes. 263.89 million shares or 3.63% more from 254.64 million shares in 2017Q2 were reported. Lau Assocs Llc holds 1.11% or 20,050 shares in its portfolio. Boston Private Wealth Ltd Llc reported 190,377 shares. Amp Invsts accumulated 142,148 shares. Cornerstone Advsrs accumulated 0.01% or 134 shares. California State Teachers Retirement Sys reported 485,284 shares stake. Ancora Advisors Ltd Liability Corp invested in 10,034 shares. Mcf Advsrs Lc reported 420 shares. Jnba Financial Advsrs accumulated 0.01% or 795 shares. Parsons Cap Ri owns 9,136 shares for 0.08% of their portfolio. State Farm Mutual Automobile Ins Co invested 0.04% of its portfolio in Cerner Corporation (NASDAQ:CERN). Victory Cap Mgmt has invested 0% in Cerner Corporation (NASDAQ:CERN). Panagora Asset Mgmt reported 15,661 shares. Teachers Retirement Sys Of The State Of Kentucky stated it has 32,500 shares or 0.03% of all its holdings. Geode Mngmt Ltd Liability reported 3.66 million shares or 0.1% of all its holdings. Cornerstone Capital Mgmt Ltd Co invested in 0.16% or 277,698 shares.

Creative Planning, which manages about $13.73 billion and $21.53B US Long portfolio, upped its stake in Applied Optoelectronics Inc (NASDAQ:AAOI) by 19,339 shares to 21,139 shares, valued at $1.37 million in 2017Q3, according to the filing. It also increased its holding in Ishares Tr (IJR) by 7,949 shares in the quarter, for a total of 395,054 shares, and has risen its stake in Vanguard Scottsdale Fds (VCSH).

Among 26 analysts covering Cerner Corporation (NASDAQ:CERN), 13 have Buy rating, 1 Sell and 12 Hold. Therefore 50% are positive. Cerner Corporation had 87 analyst reports since August 5, 2015 according to SRatingsIntel. Deutsche Bank maintained Cerner Corporation (NASDAQ:CERN) on Sunday, August 23 with “Buy” rating. On Monday, June 5 the stock rating was maintained by Piper Jaffray with “Buy”. The rating was maintained by Robert W. Baird with “Hold” on Wednesday, June 7. The rating was maintained by Robert W. Baird on Thursday, August 31 with “Hold”. The company was maintained on Wednesday, November 4 by Oppenheimer. The stock of Cerner Corporation (NASDAQ:CERN) earned “Hold” rating by Oppenheimer on Monday, July 31. The rating was maintained by Jefferies on Tuesday, July 4 with “Buy”. The stock of Cerner Corporation (NASDAQ:CERN) earned “Market Outperform” rating by Avondale on Wednesday, October 21. On Sunday, July 9 the stock rating was maintained by Cantor Fitzgerald with “Buy”. Cantor Fitzgerald maintained Cerner Corporation (NASDAQ:CERN) on Tuesday, October 10 with “Buy” rating.